Global Gene Panel Market to Grow at Steady Rate in the Near Future
The growth of this market is mainly driven by factors such as the increasing prevalence of chronic diseases, growing company initiatives, and growing adoption of gene panels owing to their benefits such as cost-efficiency and simplified the workflow.
The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%.Target Audience for...
Gene Panel Market – Emerging Technological Innovations | Global Industry Growth Dynamics
The report “Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) – Global Forecast to 2023″, The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion...
Gene Panel Market: Diff. Strategies Adopted by Major Leaders to Retain Their Position in the Global Market
Agreements, partnerships, joint ventures, and collaboration accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018.
Some of the key players in the Gene Panels Market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), ), Novogene Corporation (China), F. Hoffmann-La...
Gene Panel Market: Growth Opportunities in the Emerging Markets
The growth of this market is mainly driven by factors such as the increasing prevalence of chronic diseases, growing company initiatives, and growing adoption of gene panels owing to their benefits such as cost-efficiency and simplified the workflow.
Restraints:
# Issues Related to the Security of Genetic Data
Opportunities:
# Government Initiatives in Population Sequencing
# Growth Opportunities...
Growth Opportunities of Gene Panel Market in Emerging Markets
The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. The growth of this market is mainly driven by increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic partnerships, collaborations, and new product launches), and growing adoption of gene panels owing to their benefits.
Download PDF Brochure...